Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Understanding who benefits most helps you prepare
Many clients begin to see improvements after a series of sessions, with results continuing to develop over time as collagen production increases
News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s
Oral formulations might enable obesity treatment to move decisively into primary care, extending its reach well beyond todays specialist base and giving access to greater numbers of patients earlier in the course of the disease
Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial
Plus, we serve patients in 48 states, and no insurance is required to get started
US$ 26.88
US$ 29.03
US$ 20.00
US$ 22.64
